IUS Publications
Found 24 results
Filters: Author is Uversky, Vladimir N. [Clear All Filters]
, “Biomaterials in personalized drug delivery: innovations, challenges, and future directions”, PeerJ, vol. 14, p. e20982, 2026.
, “Crowding and in-Cell Crystallization”, vol. 109, Cham: Springer Nature Switzerland, 2025, pp. 415 - 432.
, “Crowding and in-Cell Crystallization”, vol. 109, Cham: Springer Nature Switzerland, 2025, pp. 415 - 432.
, “Effects of Molecular Crowding on the Structural, Dynamic, and Functional Properties of Biological Macromolecules: A General Overview”, vol. 109, Cham: Springer Nature Switzerland, 2025, pp. 15 - 39.
, “Effects of Molecular Crowding on the Structural, Dynamic, and Functional Properties of Biological Macromolecules: A General Overview”, vol. 109, Cham: Springer Nature Switzerland, 2025, pp. 15 - 39.
, “Intrinsic factors behind long COVID: exploring the role of nucleocapsid protein in thrombosis”, PeerJ, vol. 13, p. e19429, 2025.
, “Intrinsic Factors Behind the Long‐COVID: V. Immunometabolic Disorders”, Journal of Cellular Biochemistry, vol. 126, no. 1, 2025.
, “Looking at bacterial cell poles from a liquid-liquid phase separation of intrinsically disordered proteins perspective”, Current Research in Structural Biology, vol. 10, p. 100175, 2025.
, “Molecular genomic insights into melanoma associated proteins PRAME and BAP1”, Journal of Biomolecular Structure and Dynamics, pp. 1 - 31, 2025.
, PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE Navigating the Complexities of SARS-CoV-2 Immunobiology: The Science Behind the COVID-19 Pandemic, vol. 213. Elsevier Academic Press, 2025.
, “Subcellular Biochemistry(Macro)Molecular CrowdingMacromolecular Crowding in Cytoplasm and Cellular Organelles”, vol. 109, Cham: Springer Nature Switzerland, 2025, pp. 209 - 240.
, “Subcellular Biochemistry(Macro)Molecular CrowdingMacromolecular Crowding in Cytoplasm and Cellular Organelles”, vol. 109, Cham: Springer Nature Switzerland, 2025, pp. 209 - 240.
, “The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications”, Viruses, vol. 17, no. 7, p. 985, 2025.
, “Advances in Glioblastoma Multiforme: Integrating Therapy and Pathology Perspectives”, Pathology - Research and Practice, p. 155285, 2024.
, “The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems”, Biomedicines, vol. 12, no. 4, p. 913, 2024.
, “Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines”, Autoimmunity Reviews, vol. 23, no. 3, p. 103508, 2024.
, “A comprehensive review of PRAME and BAP1 in melanoma: Genomic instability and immunotherapy targets”, Cellular Signalling, vol. 124, p. 111434, 2024.
, “Interplay between Multisystem Inflammatory Syndrome in Children, Interleukin 6, Microbiome, and Gut Barrier Integrity”, Immuno, vol. 4, no. 3, pp. 226 - 246, 2024.
, “The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions”, Cytokine & Growth Factor Reviews, 2024.
, “Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic TargetsAbstract:”, CNS & Neurological Disorders - Drug Targets, vol. 23, 2024.
, “Polyphenol stability and bioavailability in cell culture medium: Challenges, limitations and future directions”, International Journal of Biological Macromolecules, vol. 279, p. 135232, 2024.
, “The role of the gut microbiome in gastrointestinal cancers”, Cellular Signalling, vol. 115, p. 111013, 2024.
, “SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants”, Computers in Biology and Medicine, vol. 170, p. 107899, 2024.
, “COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence”, Biomedicines, vol. 11, no. 5, p. 1469, 2023.